P53 and survivin expression in renal cell carcinoma

OBJECTIVE: Mutation of p53 is detected in more than 50% of human cancers, expression of p53 has a potential prognostic value in patients with renal cell carcinoma (RCC). Survivin is a member of the inhibitor of apoptosis protein family, its overexpression is observed in many malignancies, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Radovanović, Milan, Petrović, Miloš, Šantrić, Veljko, Milojević, Bogomir, Zubelić, Aleksa, Isaković, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252781/
https://www.ncbi.nlm.nih.gov/pubmed/37304521
http://dx.doi.org/10.4103/ua.ua_91_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252781/
https://www.ncbi.nlm.nih.gov/pubmed/37304521
http://dx.doi.org/10.4103/ua.ua_91_22

Ejemplares similares